{
    "eid": "2-s2.0-85065713794",
    "title": "Doripenem dosing regimens in Asian critically ill patients with continuous renal replacement therapy",
    "cover-date": "2019-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Critical Care and Intensive Care Medicine",
            "@code": "2706",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Weerachai Chaijamorn",
        "Punyawee Puchsaka",
        "Sutthiporn Pattharachayakul",
        "Taniya Charoensareerat",
        "Nattachai Srisawat",
        "Apinya Boonpeng",
        "Chalermsri Pummangura"
    ],
    "citedby-count": 3,
    "ref-count": 26,
    "ref-list": [
        "We underdose antibiotics in patients on CRRT",
        "Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients",
        "Antibiotic dosing in patients with kidney injury; \u201cenough but not too much\u201d",
        "Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury",
        "Doripenem",
        "Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF)",
        "Removal of doripenem during hemodialysis and the optimum dosing regimen for patients undergoing hemodialysis",
        "Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem",
        "Doripenem treatment during continuous renal replacement therapy",
        "Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration",
        "Pharmacokinetics of doripenem during high volume hemodiafiltration in patients with septic shock",
        "In silico trials using Monte Carlo simulation to evaluate ciprofloxacin and levofloxacin dosing in critically ill patients receiving prolonged intermittent renal replacement therapy",
        "Use of Monte Carlo simulations to determine optimal Carbapenem dosing in critically ill patients receiving prolonged intermittent renal replacement therapy",
        "Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study",
        "Drug dosing in continuous renal replacement therapy: general rules",
        "Clinical research: The epidemiology and prognostic factors for mortality in intensive care unit patients with acute kidney injury in South East Asia",
        "Management of renal replacement therapy in ICU patients: an international survey",
        "Lexi-Comp Online\u2122, Lexi-Drugs Online\u2122",
        "Standardization of pharmacokinetic/pharmacodynamics (PK/PD) terminology for anti-infective drugs: an update",
        "Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations",
        "Antimicrobial pharmacodynamics: critical interactions of \u2018bug and drug",
        "Performance standards for antimicrobial susceptibility testing, ed 26",
        "Beta-lactam antibiotic concentrations during continuous renal replacement therapy",
        "Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy",
        "Effect of hemopurification rate on doripenem pharmacokinetics in critically ill patients receiving high-flow continuous hemodiafiltration"
    ],
    "affiliation": [
        {
            "affiliation-city": "Phayao",
            "@id": "60114221",
            "affilname": "University of Phayao",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60114221",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022182",
            "affilname": "Siam University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022182",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Siam University"
    ]
}